User contributions
Jump to navigation
Jump to search
- 02:08, 25 April 2024 diff hist +65 m Peripheral T-cell lymphoma current
- 02:05, 25 April 2024 diff hist +50 m Peripheral T-cell lymphoma →Mogamulizumab monotherapy {{#subobject:8d8ae3|Regimen=1}}
- 02:04, 25 April 2024 diff hist +182 m Peripheral T-cell lymphoma →Lenalidomide monotherapy {{#subobject:372121|Regimen=1}}
- 02:00, 25 April 2024 diff hist +63 m Peripheral T-cell lymphoma →Forodesine monotherapy {{#subobject:2310b4|Regimen=1}}
- 01:58, 25 April 2024 diff hist +84 m Peripheral T-cell lymphoma →Chidamide monotherapy {{#subobject:5a869f|Regimen=1}}
- 01:56, 25 April 2024 diff hist +65 m Peripheral T-cell lymphoma
- 01:55, 25 April 2024 diff hist +63 m Peripheral T-cell lymphoma →DA-EPOCH {{#subobject:9b4e41|Regimen=1}}
- 01:53, 25 April 2024 diff hist +66 m Peripheral T-cell lymphoma →CHOEP-14 {{#subobject:e84b92|Regimen=1}}
- 01:53, 25 April 2024 diff hist +43 m Peripheral T-cell lymphoma →A-CHOP {{#subobject:75a3d2|Regimen=1}}
- 01:50, 25 April 2024 diff hist -14 m Urothelial carcinoma →References current
- 01:49, 25 April 2024 diff hist +45 m Urothelial carcinoma →References
- 01:48, 25 April 2024 diff hist +45 m Urothelial carcinoma →References
- 01:44, 25 April 2024 diff hist +42 m Urothelial carcinoma →Pembrolizumab monotherapy {{#subobject:7fc2f6|Regimen=1}}
- 01:42, 25 April 2024 diff hist +61 m Urothelial carcinoma →Nivolumab monotherapy {{#subobject:23ugd2|Regimen=1}}
- 01:40, 25 April 2024 diff hist +45 m Bladder cancer →References current
- 01:37, 25 April 2024 diff hist +890 m Multiple myeloma, relapsed-refractory current
- 23:08, 24 April 2024 diff hist +1,996 m Chronic lymphocytic leukemia current
- 23:01, 24 April 2024 diff hist +1 m Immune effector cells toxicity management →Consensus recommendations current
- 23:01, 24 April 2024 diff hist +313 m Immune effector cells toxicity management →ASTCT
- 12:52, 24 April 2024 diff hist +1,681 m Nasopharyngeal carcinoma →Locally advanced disease, definitive chemoradiotherapy
- 12:51, 24 April 2024 diff hist +35,495 m Editing test page current
- 11:07, 24 April 2024 diff hist +2,292 m Acute myeloid leukemia →Relapsed or refractory, salvage therapy current
- 11:06, 24 April 2024 diff hist +991 m Acute myeloid leukemia →MEC {{#subobject:48e49b|Regimen=1}}
- 11:03, 24 April 2024 diff hist +4,267 Acute myeloid leukemia →Azacitidine monotherapy {{#subobject:531b70|Regimen=1}}
- 17:34, 23 April 2024 diff hist +13 m Drug index →By Category current
- 17:33, 23 April 2024 diff hist +4 m Drug index →Medications by Year of Approval
- 17:33, 23 April 2024 diff hist +42 m Drug index →Medications by Condition
- 17:27, 23 April 2024 diff hist +1,894 m Non-small cell lung cancer, EGFR-mutated →Cisplatin & Pemetrexed {{#subobject:26acke|Regimen=1}} current
- 17:25, 23 April 2024 diff hist +1,184 m Non-small cell lung cancer, EGFR-mutated →Carboplatin & Pemetrexed {{#subobject:60cb1d|Regimen=1}}
- 17:09, 23 April 2024 diff hist +1 m Editing test page →External beam radiotherapy
- 17:09, 23 April 2024 diff hist +3 m Editing test page →External beam radiotherapy
- 17:02, 23 April 2024 diff hist +3 m Nasopharyngeal carcinoma →Radiotherapy
- 17:01, 23 April 2024 diff hist +3 m Nasopharyngeal carcinoma →Regimen variant #1, 30 mg/m2 weekly dosing {{#subobject:c0e2e2|Variant=1}}
- 17:00, 23 April 2024 diff hist +1 m Nasopharyngeal carcinoma →Regimen variant #4, 100 mg/m2 x 2 {{#subobject:b44282|Variant=1}}
- 17:00, 23 April 2024 diff hist 0 m Nasopharyngeal carcinoma →Radiotherapy
- 16:57, 23 April 2024 diff hist +3 m Head and neck cancer →Regimen variant #3, 30 mg/m2 weekly dosing {{#subobject:71731a|Variant=1}}
- 16:37, 23 April 2024 diff hist +1,226 m Non-small cell lung cancer, EGFR-mutated →Carboplatin & Pemetrexed {{#subobject:60cb1d|Regimen=1}}
- 16:24, 23 April 2024 diff hist +2,433 m Colorectal cancer, RAS wild-type →FOLFIRI & Cetuximab {{#subobject:11cf7b|Regimen=1}} current
- 16:15, 23 April 2024 diff hist -1,072 m Colorectal cancer, RAS wild-type
- 12:44, 23 April 2024 diff hist +1,934 m Non-small cell lung cancer, nonsquamous →Carboplatin, Pemetrexed, Atezolizumab {{#subobject:a4hzv7|Regimen=1}} current
- 12:34, 23 April 2024 diff hist +2,209 m Breast cancer, ER-positive →Anastrozole monotherapy {{#subobject:f8140f|Regimen=1}} current
- 11:31, 23 April 2024 diff hist +150 m How I Treat →Transplantation current
- 11:30, 23 April 2024 diff hist +172 m How I Treat →Myelodysplastic syndrome (MDS)
- 23:40, 22 April 2024 diff hist +30 m Classical Hodgkin lymphoma, pediatric current
- 23:37, 22 April 2024 diff hist +7 m Small cell lung cancer →Preceding treatment current
- 23:37, 22 April 2024 diff hist +6 m Prostate cancer →Subsequent treatment current
- 23:16, 22 April 2024 diff hist -1 m Non-small cell lung cancer →Radiotherapy current
- 23:15, 22 April 2024 diff hist -25 m Non-small cell lung cancer →Subsequent treatment
- 23:14, 22 April 2024 diff hist +13 m Non-small cell lung cancer →Subsequent treatment
- 23:12, 22 April 2024 diff hist +7 m Multiple myeloma - historical →Preceding treatment current